CVS Health price target raised to $74 from $58 at RBC Capital
RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform ...
CyberArk price target raised to $481 from $410 at RBC Capital
RBC Capital raised the firm’s price target on CyberArk (CYBR) to $481 from $410 and keeps an Outperform rating on the shares. The company posted a strong quarter with all metrics and initial 2025 ...
Walmart is retail king again. Can it keep the crown?
After years of lagging behind the retail stars Costco Wholesale and Amazon.com, Walmart is catching up quickly. Its shares rose 72% in 2024, and are up another 16% so far this year. Walmart has become ...
Clearwater Analytics CEO Sandeep Sahai sells $1.38 million in stock
Clearwater Analytics Holdings , Inc. (NYSE:CWAN), a $6.9 billion market cap company, saw its Chief Executive Officer Sandeep Sahai recently sell a significant portion of his holdings. According to a ...
Atkore receives DOJ subpoena over product pricing
Atkore Inc. (NYSE:ATKR), a manufacturer specializing in electrical supplies with annual revenue of $3.07 billion and strong liquidity metrics, has been served with a grand jury subpoena from the U.S.